Hudson Edge Investment Partners’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-1,643
Closed -$205K 159
2017
Q2
$205K Buy
+1,643
New +$195K 0.03% 157
2016
Q4
Sell
-1,813
Closed -$229K 165
2016
Q3
$229K Sell
1,813
-299
-14% -$36.9K 0.03% 155
2016
Q2
$247K Sell
2,112
-42,142
-95% -$4.77M 0.04% 148
2016
Q1
$4.58M Buy
44,254
+536
+1% +$51.9K 0.45% 72
2015
Q4
$4.35M Sell
43,718
-3,590
-8% -$351K 0.42% 73
2015
Q3
$4.31M Buy
47,308
+1,597
+3% +$160K 0.23% 76
2015
Q2
$4.85M Sell
45,711
-732
-2% -$81K 0.2% 74
2015
Q1
$5.3M Sell
46,443
-28,809
-38% -$3.29M 0.22% 66
2014
Q4
$8.29M Sell
75,252
-16,639
-18% -$1.75M 0.3% 65
2014
Q3
$8.97M Sell
91,891
-721
-0.8% -$70.9K 0.33% 60
2014
Q2
$9.34M Buy
92,612
+638
+0.7% +$62.3K 0.33% 57
2014
Q1
$8.45M Sell
91,974
-618
-0.7% -$57K 0.32% 64
2013
Q4
$8.38M Sell
92,592
-4,346
-4% -$376K 0.32% 66
2013
Q3
$7.73M Sell
96,938
-2,390
-2% -$188K 0.32% 68
2013
Q2
$7.23M Buy
+99,328
New +$7.43M 0.29% 63

Other funds holding ZBH

Hudson Edge Investment Partners's ZBH Position: Q3 2017 in Review

Hudson Edge Investment Partners sold out of Zimmer Biomet (ZBH) in Q3 2017, closing a stake of 1,643 shares — an estimated $205K sold.

Hudson Edge Investment Partners first reported a position in ZBH in Q2 2013 and held it in 15 quarters. The position peaked at $9.34M in Q2 2014. 818 funds tracked by Wall St. Rank hold ZBH as of Q3 2017.

  • Hudson Edge Investment Partners reported no remaining Zimmer Biomet position as of Q3 2017 after selling out during the quarter.
  • Hudson Edge Investment Partners sold 1,643 Zimmer Biomet shares in Q3 2017, an estimated $205K.
  • Hudson Edge Investment Partners first reported a position in Zimmer Biomet in Q2 2013 and held it in 15 quarters.
  • Hudson Edge Investment Partners's Zimmer Biomet position peaked at $9.34M in Q2 2014.
  • 818 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2017.

Based on Hudson Edge Investment Partners's 13F filing for Q3 2017, filed 13 Nov 2017.